MX9703642A - Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana. - Google Patents
Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.Info
- Publication number
- MX9703642A MX9703642A MX9703642A MX9703642A MX9703642A MX 9703642 A MX9703642 A MX 9703642A MX 9703642 A MX9703642 A MX 9703642A MX 9703642 A MX9703642 A MX 9703642A MX 9703642 A MX9703642 A MX 9703642A
- Authority
- MX
- Mexico
- Prior art keywords
- peptide analogues
- multiple sclerosis
- myelin basic
- basic protein
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proveen análogos de péptido de proteína básica de mielina humana que contienen los residuos 87-99. El residuo 91 de los análogos de péptido es alterado del residuo de L-lisina encontrado en la proteína nativa a cualquier otro aminoácido. Se proveen composiciones farmacéuticas de los análogos de péptido. Además, los análogos de péptido se administran a pacientes con esclerosis multiple.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34207894A | 1994-11-18 | 1994-11-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9703642A true MX9703642A (es) | 1998-11-29 |
Family
ID=23340234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9703642A MX9703642A (es) | 1994-11-18 | 1997-05-16 | Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana. |
Country Status (9)
Country | Link |
---|---|
US (4) | US6369033B1 (es) |
EP (2) | EP1172376A1 (es) |
JP (1) | JPH10509714A (es) |
AT (1) | ATE213499T1 (es) |
AU (1) | AU721898B2 (es) |
CA (1) | CA2205532A1 (es) |
DE (1) | DE69525544T2 (es) |
MX (1) | MX9703642A (es) |
WO (1) | WO1996016085A1 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7090982B2 (en) | 1991-10-22 | 2006-08-15 | The Governors Of The University Of Alberta | Methods of predicting therapeutic efficacy of treatment of a multiple sclerosis patient |
US6252040B1 (en) | 1991-10-22 | 2001-06-26 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
ES2172044T3 (es) * | 1992-04-09 | 2002-09-16 | Autoimmune Inc | Supresion de la proliferacion de celulas t usando fragmentos peptidicos de proteina basica de mielina. |
HUT77047A (hu) * | 1994-10-25 | 1998-03-02 | Immulogic Pharmaceutical Corporation | Szklerózis multiplex kezelésére szolgáló készítmények és kezelések |
US6379670B1 (en) | 1994-11-18 | 2002-04-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US6251396B1 (en) * | 1994-11-18 | 2001-06-26 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US6329499B1 (en) | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
ATE213499T1 (de) * | 1994-11-18 | 2002-03-15 | Neurocrine Biosciences Inc | Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose |
WO1996028470A2 (en) * | 1995-03-09 | 1996-09-19 | Neurocrine Biosciences, Inc. | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis |
AU1874997A (en) * | 1996-02-15 | 1997-09-02 | Pangenetics B.V. | Molecules for the induction of immunological tolerance |
US20020072493A1 (en) | 1998-05-19 | 2002-06-13 | Yeda Research And Development Co. Ltd. | Activated T cells, nervous system-specific antigens and their uses |
US6541608B1 (en) * | 1999-02-23 | 2003-04-01 | Baylor College Of Medicine | T cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
US20040072222A1 (en) * | 2001-03-23 | 2004-04-15 | John Matsoukas | Peptide analogues of myelin basic protein epitopes in the treatment of experimental autoimmune encephalomyelitis (eae) and multiple sclerosis (ms) |
US7658926B2 (en) * | 2001-09-14 | 2010-02-09 | Opexa Pharmaceuticals, Inc. | Autologous T-cell vaccines materials and methods |
CN100567987C (zh) * | 2002-08-08 | 2009-12-09 | 贝勒医学院 | T细胞疫苗及其制备方法 |
CN101448517A (zh) | 2005-04-19 | 2009-06-03 | 伊莱利利公司 | 用于疾病免疫干预的单价和多价合成多糖抗原 |
DK2016414T3 (en) * | 2006-05-05 | 2015-12-07 | Opexa Therapeutics | T-cell vaccine |
JP5810413B2 (ja) | 2008-12-19 | 2015-11-11 | バイオジェン インターナショナル ニューロサイエンス ゲーエムベーハー | ヒト抗アルファシヌクレイン自己抗体 |
US20140348861A1 (en) | 2011-05-05 | 2014-11-27 | National Institute Of Immunology | Synthetic peptides and random copolymers for the treatment of autoimmune disorders |
WO2012177972A1 (en) | 2011-06-23 | 2012-12-27 | Biogen Idec International Neuroscience Gmbh | Anti-alpha synuclein binding molecules |
CN103102393B (zh) * | 2013-01-30 | 2015-01-07 | 北京大学 | 一种多肽及其在制备抑郁症治疗药物中的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5468481A (en) * | 1988-06-23 | 1995-11-21 | Amergen, Inc. | MHC class II-peptide conjugates useful in ameliorating autoimmunity |
ATE157257T1 (de) * | 1990-03-02 | 1997-09-15 | Autoimmune Inc | Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen |
US5858980A (en) * | 1990-03-30 | 1999-01-12 | Autoimmune, Inc. | Peptide fragments of myelin basic protein |
CA2110055C (en) * | 1991-05-31 | 2002-08-20 | Arthur A. Vandenbark | T cell receptor peptides as therapeutics for immune-related disease |
CA2053799C (en) * | 1991-10-22 | 2002-03-12 | Kenneth G. Warren | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
ES2172044T3 (es) * | 1992-04-09 | 2002-09-16 | Autoimmune Inc | Supresion de la proliferacion de celulas t usando fragmentos peptidicos de proteina basica de mielina. |
AU695801B2 (en) * | 1993-09-22 | 1998-08-20 | Board Of Trustees Of The Leland Stanford Junior University | Interaction of T-cell receptors and antigen in autoimmune disease |
US6329499B1 (en) * | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
ATE213499T1 (de) * | 1994-11-18 | 2002-03-15 | Neurocrine Biosciences Inc | Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose |
-
1995
- 1995-11-16 AT AT95942842T patent/ATE213499T1/de not_active IP Right Cessation
- 1995-11-16 CA CA002205532A patent/CA2205532A1/en not_active Abandoned
- 1995-11-16 DE DE69525544T patent/DE69525544T2/de not_active Expired - Fee Related
- 1995-11-16 EP EP01115315A patent/EP1172376A1/en not_active Withdrawn
- 1995-11-16 JP JP8516910A patent/JPH10509714A/ja not_active Ceased
- 1995-11-16 EP EP95942842A patent/EP0792286B1/en not_active Expired - Lifetime
- 1995-11-16 WO PCT/US1995/014402 patent/WO1996016085A1/en active IP Right Grant
- 1995-11-16 AU AU44057/96A patent/AU721898B2/en not_active Ceased
-
1997
- 1997-05-16 MX MX9703642A patent/MX9703642A/es not_active Application Discontinuation
- 1997-10-20 US US08/953,937 patent/US6369033B1/en not_active Expired - Fee Related
-
2001
- 2001-11-19 US US09/989,476 patent/US6489299B2/en not_active Expired - Fee Related
-
2002
- 2002-10-11 US US10/270,707 patent/US6740638B2/en not_active Expired - Fee Related
-
2004
- 2004-04-08 US US10/820,983 patent/US20040214775A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0792286B1 (en) | 2002-02-20 |
WO1996016085A1 (en) | 1996-05-30 |
US6740638B2 (en) | 2004-05-25 |
US20040214775A1 (en) | 2004-10-28 |
DE69525544D1 (de) | 2002-03-28 |
US20020058627A1 (en) | 2002-05-16 |
JPH10509714A (ja) | 1998-09-22 |
AU4405796A (en) | 1996-06-17 |
EP1172376A1 (en) | 2002-01-16 |
US20030114380A1 (en) | 2003-06-19 |
US6489299B2 (en) | 2002-12-03 |
CA2205532A1 (en) | 1996-05-30 |
ATE213499T1 (de) | 2002-03-15 |
US6369033B1 (en) | 2002-04-09 |
AU721898B2 (en) | 2000-07-20 |
DE69525544T2 (de) | 2002-08-22 |
EP0792286A1 (en) | 1997-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9703642A (es) | Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana. | |
MX9703643A (es) | Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana. | |
AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
TW343198B (en) | Cyclopeptides useful as adhesion inhibitors, process for the preparation thereof, and pharmaceutical composition containing them | |
ATE73459T1 (de) | Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten. | |
EP1077070A3 (en) | Oral drug delivery compositions | |
ATE108662T1 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
WO1996028470A3 (en) | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis | |
HUP0003592A2 (hu) | LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények | |
CA2303395A1 (en) | Treatment of obesity | |
BR0213291A (pt) | Composição e método para tratamento de diabetes | |
RU99103692A (ru) | Аминокислотные композиции и их применение при иммунодепрессии | |
MY124560A (en) | Amino acid compositions and use thereof in immunosuppression | |
HUT58765A (en) | Process for producing peptide compounds and pharmaceutical compositions containing them as active components | |
GR3001922T3 (en) | Use of n,n'-bis-l-amino acid-l-cystin peptides in amino acid preparations for oral and parenteral administration | |
DE69430416T2 (de) | Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen | |
RU95120588A (ru) | Циклогексапептиды, их смеси, способ их получения и применения | |
DE3462692D1 (en) | Pharmacologically active peptides | |
EP0248231A3 (en) | Pharmacologically active peptides | |
YU64192A (sh) | Analozi insulina | |
KR920700224A (ko) | 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제 | |
DE3162674D1 (en) | A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |